Study Summary
This trial is testing whether a 3-month course of tetracycline is better than a 3-month course of placebo at improving acne. Patients will be randomly assigned to one of the two treatments and will not know which they are receiving. The study will last for 6 months.
- Lyme Disease
- Post-Lyme Disease Syndrome
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 1 Secondary · Reporting Duration: 36 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Tetracycline First
1 of 2
Placebo First
1 of 2
Active Control
Non-Treatment Group
60 Total Participants · 2 Treatment Groups
Primary Treatment: Tetracycline First · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 13th, 2021
Last Reviewed: November 8th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| North Carolina | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Johns Hopkins Lyme Disease Research Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |